<DOC>
	<DOCNO>NCT02357485</DOCNO>
	<brief_summary>This safety feasibility study use autologous adipose-derived stromal cell ( ADSC ) , stromal vascular fraction ( SVF ) , treat 8 osteoarthritic ( OA ) knees 6 patient grade I III ( K-L scale ) initial pain 4 great 10 point scale , Institutional Review Board ( IRB ) approve protocol .</brief_summary>
	<brief_title>ADSC Injections Pain Management Osteoarthritis Human Knee Joint</brief_title>
	<detailed_description>This safety feasibility study use autologous adipose-derived stromal cell , stromal vascular fraction , treat 8 osteoarthritic knee 6 patient grade I III ( K-L scale ) initial pain 4 great 10 point scale , IRB-approved protocol . Evaluation safety intra-articular injection stromal vascular fraction cell primary objective study . Adipose-derived stromal vascular cell obtain enzymatic disaggregation lipoaspirate , resuspend 3 ml Lactated Ringer 's Solution , inject directly intra-articular space mean 12 million viable nucleated SVF cell per knee .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>voluntarily provide write Informed Consent age 2070 male female grade IIII radiologically document OA one knees American Society Anaesthesiologists ( ASA ) physical status class III â€¢ BMI le 35 knee pain grade great 3 10 screening questionnaire able speak , read understand English patient parameter fall outside inclusion criterion current oral parenteral steroid blood thinner use hyaluronic acidbased injection affect knee joint within previous six month corticosteroid injection affect knee joint within previous three month end stage ( Grade IV ) OA</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>ADSC</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>knee</keyword>
	<keyword>adipose</keyword>
</DOC>